Literature DB >> 8833555

Propofol compatibility with other intravenous drug products: two new methods of evaluating IV emulsion compatibility.

M R Michaels1, G L Stauffer, D P Haas.   

Abstract

OBJECTIVE: To determine the physical compatibility of propofol injection with 77 other drug products using two methods not previously reported.
DESIGN: Each of 77 drug products were mixed with (1) an equal volume of propofol injection, (2) an equal volume of propofol injection with methylene blue added, and (3) an equal volume of the separated aqueous phase of propofol injection. The mixtures were observed for physical changes, and the turbidity of the aqueous phase mixtures was measured by nephelometry.
SETTING: A university-affiliated urban teaching hospital. MAIN OUTCOME MEASURES: Observed physical changes or changes in turbidity. RESULT: Of the 77 drugs tested, 69 showed immediate evidence of physical change, and the other 8 were found incompatible within 72 hours.
CONCLUSIONS: Practitioners should not mix the immediately incompatible products with propofol by administering them in the same intravenous line. Caution should be used in simultaneous administration of the other drugs. The new methods were useful in detecting incompatibilities in emulsions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8833555     DOI: 10.1177/106002809603000303

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  3 in total

1.  Physicochemical compatibility and emulsion stability of propofol with commonly used analgesics and sedatives in an intensive care unit.

Authors:  Franziska Gersonde; Swantje Eisend; Nils Haake; Thomas Kunze
Journal:  Eur J Hosp Pharm       Date:  2016-09-29

2.  Stability of azasetron-dexamethasone mixture for chemotherapy-induced nausea and vomiting administration.

Authors:  Bao-Xia Fang; Fu-Chao Chen; Dan Zhu; Jun Guo; Lin-Hai Wang
Journal:  Oncotarget       Date:  2017-10-31

Review 3.  Clinical Pharmacokinetics and Pharmacodynamics of Propofol.

Authors:  Marko M Sahinovic; Michel M R F Struys; Anthony R Absalom
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.